Pfizer Hints at Curbing Assistance In Part D Next Year In Notice Asking Patients To Enroll In M3P

New terms for Medicare Part D beneficiaries interested in enrolling in Pfizer’s oncology patient assistance program in 2025 involve attestations that assistance is still needed after enrolling in the new M3P program and that they have not yet met the $2,000 out-of-pocket spending cap.